Tag archives


Publisher: Policy Cures Research

The 2019 G-FINDER Report:  “[This] project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D) of new products to prevent, diagnose, control or cure neglected diseases in developing countries. It provides an up-to-date analysis of how R&D investments are being allocated across diseases and product types, funding trends over time, and where the potential gaps lie. This is the twelfth annual G-FINDER report, providing new data on investments made in financial
year 2018. In all, 262 organisations completed the survey for FY2018, which covered 36 neglected diseases and all relevant product types – drugs, vaccines, biologics, diagnostics, microbicides and vector control products (chemical and biological control agents, and reservoir targeted vaccines) – as well as basic research.”

This entry was posted in and tagged , , , on by .

Publisher:  EHRA

“This case study looks at the challenges faced in sustaining HIV prevention programmes among KAPs, implemented primarily by civil society organisations (CSO’s), as a result of the withdrawal of the Global Fund through the transition period of 2020 to 2022 and the lack of government capacity and resources to maintain the already limited services that will likely result in the re-emergence of HIV epidemics among people who inject drugs (PWID), sex workers (SW) and men who have sex with men (MSM).”

This entry was posted in and tagged , , on by .

People with HIV, tuberculosis and malaria talk about their experiences and the connection between human rights and HIV work.

Our friends at Action Against AIDS conducted three interviews to discuss the connections between human rights and HIV work. The videos, embedded below, highlight the needs of people who are all too often marginalized and emphasize the need to focus on human rights principles. The interviewees share their concerns if we loose focus and start to chip away the gains we have made.

Maurine Murenga, a HIV-positive mother from Kenya, and GFAN Speaker , explains the importance of access to medicines for the treatment and prevention of HIV and malaria.

This entry was posted in Blog and tagged , on by .

Publisher: UNAIDS

“The struggle to end the AIDS epidemic continues to be inextricably linked with the struggle to end
human rights violations, including discrimination and violence against women and girls and the
marginalization and criminalization of key populations—sex workers, people who use drugs, gay men
and other men who have sex with men, transgender people and prisoners.

This report argues that power in fact rests in the hands of the people, as can be seen in countless local, national and international movements to redistribute power and bring greater attention to neglected issues.”

This entry was posted in and tagged on by .

In advance of World AIDS Day on Sunday December 1, here are a number of resources you can use in your advocacy and on social media. 

Spotlight on HIV : Highlighting the critical need for increased funding Video & Photo Stories : Erika, Loyce, Serge & Clara Social Media : Sample posts for Twitter & Facebook Other Resources : Additional tools for your advocacy

Spotlight on HIV:

A resource with information on why investing in HIV is critical.

Spotlight on HIV Download

Video and Photo Stories:

The videos and photo stories below share the voices of our speakers.  Their stories highlight the successes of the Global Fund in saving lives but also the work that still needs to be done.

Video: Erika Castellanos – Belize
Erika shares her struggles accessing medical treat...

This entry was posted in Blog and tagged , on by .

Publisher:  World Health Organisation (WHO)

“The World Health Organization (WHO) has updated its guidance for the use of lateral flow urine lipoarabinomannan assay (LAM) in the diagnosis of tuberculosis (TB). Tests based on the detection of mycobacterial LAM antigen in urine have emerged as potential point-of-care tests for TB. The WHO Global TB Programme recommended the use of LF-LAM for the first time in 2015. Urinary LAM assays have shown greater sensitivity when used for the diagnosis of TB in people living with HIV. The sensitivity increases significantly in patients with lower CD4 cell counts. Following the new evidence, WHO is now recommending LF-LAM use to assist in diagnosis in a broader group of people, both in inpatient and outpatient settings.”

Source: Policy Update

This entry was posted in and tagged , on by .